Emre F. Yekebas
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 39
-
- Gastric Cancer Management and Outcomes 12
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment 11
- Surgery top 1%
- Pancreatitis Pathology and Treatment 30
- Esophageal Cancer Research and Treatment 18
- Esophageal and GI Pathology 12
- Gastrointestinal disorders and treatments 11
- Cancer Research top 5%
-
- Neuroendocrine Tumor Research Advances 17
- Co-authors
- Jakob R. IzbickiJussuf T. KaifiTim StrateDean BogoevskiPaulus G. SchurrYogesh K. VashistGuido SauterClaus Schneider
- Journals
- Annals of Surgery (11 papers)Journal of Gastrointestinal Surgery (6 papers)Clinical Cancer Research (4 papers)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Emre F. Yekebas
115 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 103
- Oncology 2.6k
- Pulmonary and Respiratory Medicine 1.6k
- Gastroenterology 256
- Surgery 2.1k
- Cancer Research 445
Countries citing papers authored by Emre F. Yekebas
This map shows the geographic impact of Emre F. Yekebas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emre F. Yekebas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emre F. Yekebas more than expected).
Fields of papers citing papers by Emre F. Yekebas
This network shows the impact of papers produced by Emre F. Yekebas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emre F. Yekebas. The network helps show where Emre F. Yekebas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emre F. Yekebas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 67 | |
| 2 | 2012 | 5 | |
| 3 | 2011 | 117 | |
| 4 | 2011 | 20 | |
| 5 | 2010 | 21 | |
| 6 | 2010 | 112 | |
| 7 | 2010 | 15 | |
| 8 | 2009 | 72 | |
| 9 | 2009 | 23 | |
| 10 | 2009 | 3 | |
| 11 | 2008 | 2 | |
| 12 | 2007 | 35 | |
| 13 | HSP90 inhibition is a potential therapeutic strategy in treatment of adenocarcinoma of the esophagus | 2007 | 1 |
| 14 | 2007 | 77 | |
| 15 | 2007 | 9 | |
| 16 | 2005 | 46 | |
| 17 | 2003 | 32 | |
| 18 | 2002 | 39 | |
| 19 | 2002 | 40 | |
| 20 | 2002 | 30 |
About Emre F. Yekebas
Emre F. Yekebas is a scholar working on Gastroenterology, Oncology and Surgery, having authored 115 papers that have together received 4.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (39 papers), Pancreatitis Pathology and Treatment (30 papers), Esophageal Cancer Research and Treatment (18 papers), Neuroendocrine Tumor Research Advances (17 papers), Gastric Cancer Management and Outcomes (12 papers), Esophageal and GI Pathology (12 papers), Gastrointestinal disorders and treatments (11 papers) and Gastrointestinal Tumor Research and Treatment (11 papers). The work is most often cited by research in Oncology (2.6k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Gastroenterology (256 citations). Emre F. Yekebas has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Jakob R. Izbicki, Jussuf T. Kaifi, Tim Strate, Dean Bogoevski, Paulus G. Schurr, Yogesh K. Vashist, Guido Sauter, Claus Schneider, Oliver Mann and Asad Kutup. Their work appears in journals such as Annals of Surgery, Journal of Gastrointestinal Surgery, Clinical Cancer Research, Annals of Surgical Oncology and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.